Abstract

Fibroelastomas account for less than 10% of all cardiac tumours, representing the most common valvular and the second most common cardiac benign tumour, following myxomas. Fibroelastomas are histologically benign; they can result in life-threatening complications such as stroke, acute valvular dysfunction, embolism, ventricular fibrillation, and sudden death. Surgical resection should be offered to all patients who have symptoms and to asymptomatic patients who have pedunculated lesions or tumors larger than 1 cm in diameter. Valve-sparing excision produces good long-term results in most instances. We report our surgical experience of a giant fibroelastoma in the aortic valve.

Highlights

  • IntroductionCardiac fibroelastomas are the most common benign neoplasms of the cardiac valvular structures

  • Cardiac fibroelastomas are the most common benign neoplasms of the cardiac valvular structures.Fibroelastoma is often attached to valve leaflets, most often to the aortic valve, and less frequently to the tricuspid, mitral, and pulmonary valves

  • Most cases of fibroelastoma are incidental findings because they are asymptomatic, some show a strong propensity toward embolization, causing angina, myocardial infarction, transient ischemic attack, stroke, or sudden death when the tumor is in the left side of the heart

Read more

Summary

Introduction

Cardiac fibroelastomas are the most common benign neoplasms of the cardiac valvular structures. Fibroelastoma is often attached to valve leaflets, most often to the aortic valve, and less frequently to the tricuspid, mitral, and pulmonary valves. Most cases of fibroelastoma are incidental findings because they are asymptomatic, some show a strong propensity toward embolization, causing angina, myocardial infarction, transient ischemic attack, stroke, or sudden death when the tumor is in the left side of the heart. We report our treatment of a giant aortic valve fibroelastoma

Case Report
Conflict of Interests
Findings
Discussion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.